Conatumumab: a novel monoclonal antibody against death receptor 5 for the treatment of advanced malignancies in adults (Q37923958)

From Wikidata
Jump to navigation Jump to search
scientific article published on 31 August 2011
edit
Language Label Description Also known as
English
Conatumumab: a novel monoclonal antibody against death receptor 5 for the treatment of advanced malignancies in adults
scientific article published on 31 August 2011

    Statements

    Conatumumab: a novel monoclonal antibody against death receptor 5 for the treatment of advanced malignancies in adults (English)
    31 August 2011
    1519-1524

    Identifiers

     
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit
                    edit